documents: FDA-2009-D-0137-0009
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-D-0137-0009 | FDA | FDA-2009-D-0137 | Reference 26 - "Guidance for Industry: Biological Product Deviation Reporting for Blood and Plasma Establishments, October 2006" - [re FDA-2009-D-0137-0002] | Supporting & Related Material | REF-Reference (internal unless indicated) | 2009-03-30T04:00:00Z | 2009 | 3 | 2011-06-29T19:45:14Z | 0 | 0 | 090000648092ff42 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref